European drugmakers say they are ‘losing ground’ to US and Chinese rivals
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"European drugmakers say they are ‘losing ground’ to US and Chinese rivals" is generating significant coverage in the Business category, with 5 articles from 5 distinct sources tracked by PULSE so far.
Outlets currently covering the story include CORDIS | European Commission, Reuters, Bloomberg.com and Fierce Pharma. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 56d ago.
Quick answers
Why is "European drugmakers say they are ‘losing ground’ to US and Chinese rivals" trending?
Because 5 independent news sources published 5 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (7)
- Europe Is Losing the Pharma Investment Race — But the Comeback Is Within Reach: An open letter from the Chairs of AstraZeneca, Boehringer Ingelheim, Chiesi Group, Ipsen, GSK, Novo, Novartis, Roche, and Sanofi AstraZeneca · 56d ago
- European pharma's 'slow agony' of decline draws warning from nine industry chairs FirstWord · 56d ago
- Horizon is powering the EU’s biotechnology industry, from innovation to investment CORDIS | European Commission · 56d ago
- European drugmakers call for faster trials, more spending to compete with US, China Reuters · 56d ago
- Pharma Bosses Warn European Leaders Future Investment at Risk Bloomberg.com · 56d ago
- 'Europe does not value what you do': 9 pharmas make urgent call for bloc to beef up innovation muscle Fierce Pharma · 56d ago
- European drugmakers say they are ‘losing ground’ to US and Chinese rivals theguardian.com · 56d ago
Topics
Related trends
Carney says Canada could turn to Chinese automakers if Trump trade talks fail
Prime Minister Mark Carney says Canada could turn to Chinese automakers if trade talks with the Trump administration fail to protect the Canadian auto sector.
Exclusive-Military-linked Chinese university bought Nvidia H200 chips despite US blacklist, records show
A blacklisted Chinese university with military ties acquired Nvidia H200 AI chips despite U.S. export controls, according to procurement records cited by Reuters and other outlets.
Trump says FBI investigating Nvidia boss's affair with alleged Chinese spy
President Trump said Jensen Huang told him he had no idea Alice Huang was an alleged Chinese spy during an affair.
Nvidia opens investigation after reports CEO Jensen Huang was targeted by Chinese intelligence
Nvidia has launched an independent investigation of its CEO, Jensen Huang, over allegations he was targeted by Chinese intelligence.
US believes Nvidia’s Huang had romantic relationship with alleged Chinese spy
Nvidia CEO Jensen Huang has admitted to an extramarital affair amid reports he was targeted by a Chinese spy.
Nvidia CEO called in by lawmakers over ties to alleged Chinese spy
Nvidia has launched an independent investigation after CEO Jensen Huang admitted to an extramarital affair with an alleged Chinese spy.